Doxorubicin-NO Releaser Molecular Hybrid Activatable by Green Light to Overcome Resistance in Breast Cancer Cells.
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
08 Mar 2022
08 Mar 2022
Historique:
received:
26
07
2021
accepted:
24
11
2021
entrez:
14
3
2022
pubmed:
15
3
2022
medline:
15
3
2022
Statut:
epublish
Résumé
The biological activity of a molecular hybrid (
Identifiants
pubmed: 35284722
doi: 10.1021/acsomega.1c03988
pmc: PMC8908524
doi:
Types de publication
Journal Article
Langues
eng
Pagination
7452-7459Informations de copyright
© 2022 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
ACS Med Chem Lett. 2011 Apr 04;2(7):494-7
pubmed: 24900337
ACS Med Chem Lett. 2017 Jan 30;8(3):361-365
pubmed: 28337331
Nitric Oxide. 2013 Nov 1;34:56-64
pubmed: 23416089
Acc Chem Res. 2008 Jan;41(1):69-77
pubmed: 17665872
Pharmacol Rev. 2004 Jun;56(2):185-229
pubmed: 15169927
Biomacromolecules. 2010 Feb 8;11(2):465-72
pubmed: 20085247
Expert Opin Drug Discov. 2016;11(3):281-305
pubmed: 26727036
Nat Rev Cancer. 2018 Jul;18(7):452-464
pubmed: 29643473
Bioorg Med Chem. 2016 Mar 1;24(5):967-75
pubmed: 26822567
Carcinogenesis. 1998 May;19(5):711-21
pubmed: 9635855
Nat Rev Mol Cell Biol. 2002 Mar;3(3):214-20
pubmed: 11994742
PLoS One. 2012;7(8):e43814
pubmed: 22937101
Curr Top Med Chem. 2009;9(2):119-29
pubmed: 19200000
Free Radic Biol Med. 1998 Sep;25(4-5):434-56
pubmed: 9741580
J Med Chem. 2017 Sep 28;60(18):7617-7635
pubmed: 28505442
Sci Rep. 2019 Feb 5;9(1):1430
pubmed: 30723285
Cancer Cell Int. 2014 Dec 21;14(1):142
pubmed: 25550688
Mol Pharm. 2010 Dec 6;7(6):2334-48
pubmed: 20958074
Cancer Res. 2005 Jan 15;65(2):516-25
pubmed: 15695394
Chem Soc Rev. 2010 Aug;39(8):2903-13
pubmed: 20556272
Biochem Pharmacol. 2012 Apr 15;83(8):1104-11
pubmed: 22285912
Acc Chem Res. 2011 Apr 19;44(4):289-98
pubmed: 21361269
J Pharm Biomed Anal. 2009 Sep 8;50(2):107-16
pubmed: 19473803
Mol Cancer. 2009 Nov 19;8:108
pubmed: 19925669
Nat Rev Cancer. 2006 Jul;6(7):521-34
pubmed: 16794635
Chem Commun (Camb). 2020 Jun 11;56(47):6332-6335
pubmed: 32435776
Cancer. 2003 Jun 1;97(11):2869-79
pubmed: 12767102
Mol Pharm. 2013 Jan 7;10(1):161-74
pubmed: 23186264
J Med Chem. 2010 Mar 11;53(5):1883-97
pubmed: 19924994
Adv Drug Deliv Rev. 2018 May;130:73-89
pubmed: 30012492
Cancer Res. 2001 Sep 15;61(18):6635-9
pubmed: 11559526